854 related articles for article (PubMed ID: 18661361)
21. Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.
Lemmink HH; Nillesen WN; Mochizuki T; Schröder CH; Brunner HG; van Oost BA; Monnens LA; Smeets HJ
J Clin Invest; 1996 Sep; 98(5):1114-8. PubMed ID: 8787673
[TBL] [Abstract][Full Text] [Related]
22. Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families.
Longo I; Scala E; Mari F; Caselli R; Pescucci C; Mencarelli MA; Speciale C; Giani M; Bresin E; Caringella DA; Borochowitz ZU; Siriwardena K; Winship I; Renieri A; Meloni I
Nephrol Dial Transplant; 2006 Mar; 21(3):665-71. PubMed ID: 16338941
[TBL] [Abstract][Full Text] [Related]
23. The signaling pathways of LMX1B and its role in glomerulosclerosis.
Zhou TB; Qin YH
J Recept Signal Transduct Res; 2012 Dec; 32(6):285-9. PubMed ID: 23046462
[TBL] [Abstract][Full Text] [Related]
24. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
25. A novel mutation of COL4A3 presents a different contribution to Alport syndrome and thin basement membrane nephropathy.
Hou P; Chen Y; Ding J; Li G; Zhang H
Am J Nephrol; 2007; 27(5):538-44. PubMed ID: 17726307
[TBL] [Abstract][Full Text] [Related]
26. COL4A3 mutations cause focal segmental glomerulosclerosis.
Xie J; Wu X; Ren H; Wang W; Wang Z; Pan X; Hao X; Tong J; Ma J; Ye Z; Meng G; Zhu Y; Kiryluk K; Kong X; Hu L; Chen N
J Mol Cell Biol; 2014 Dec; 6(6):498-505. PubMed ID: 25596306
[TBL] [Abstract][Full Text] [Related]
27. Carriers of Autosomal Recessive Alport Syndrome with Thin Basement Membrane Nephropathy Presenting as Focal Segmental Glomerulosclerosis in Later Life.
Deltas C; Savva I; Voskarides K; Papazachariou L; Pierides A
Nephron; 2015; 130(4):271-80. PubMed ID: 26201269
[TBL] [Abstract][Full Text] [Related]
28. The wages of thin.
Kashtan CE
J Am Soc Nephrol; 2007 Nov; 18(11):2800-2. PubMed ID: 17942944
[No Abstract] [Full Text] [Related]
29. Evidence for activation of the unfolded protein response in collagen IV nephropathies.
Pieri M; Stefanou C; Zaravinos A; Erguler K; Stylianou K; Lapathitis G; Karaiskos C; Savva I; Paraskeva R; Dweep H; Sticht C; Anastasiadou N; Zouvani I; Goumenos D; Felekkis K; Saleem M; Voskarides K; Gretz N; Deltas C
J Am Soc Nephrol; 2014 Feb; 25(2):260-75. PubMed ID: 24262798
[TBL] [Abstract][Full Text] [Related]
30. COL4A3 mutations and their clinical consequences in thin basement membrane nephropathy (TBMN).
Wang YY; Rana K; Tonna S; Lin T; Sin L; Savige J
Kidney Int; 2004 Mar; 65(3):786-90. PubMed ID: 14871398
[TBL] [Abstract][Full Text] [Related]
31. [From Alport syndrome to benign familial hematuria: clinical and genetic aspect].
Maziers N; Dahan K; Pirson Y
Nephrol Ther; 2005 May; 1(2):90-100. PubMed ID: 16895672
[TBL] [Abstract][Full Text] [Related]
32. Novel heterozygous COL4A3 mutation in a family with late-onset ESRD.
Hoefele J; Lange-Sperandio B; Ruessmann D; Glöckner-Pagel J; Alberer M; Benz MR; Nagel M; Weber LT
Pediatr Nephrol; 2010 Aug; 25(8):1539-42. PubMed ID: 20177710
[TBL] [Abstract][Full Text] [Related]
33. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.
Weber S; Strasser K; Rath S; Kittke A; Beicht S; Alberer M; Lange-Sperandio B; Hoyer PF; Benz MR; Ponsel S; Weber LT; Klein HG; Hoefele J
Pediatr Nephrol; 2016 Jun; 31(6):941-55. PubMed ID: 26809805
[TBL] [Abstract][Full Text] [Related]
34. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
[TBL] [Abstract][Full Text] [Related]
35. Nine novel COL4A3 and COL4A4 mutations and polymorphisms identified in inherited membrane diseases.
Rana K; Tonna S; Wang YY; Sin L; Lin T; Shaw E; Mookerjee I; Savige J
Pediatr Nephrol; 2007 May; 22(5):652-7. PubMed ID: 17216251
[TBL] [Abstract][Full Text] [Related]
36. Upregulated expression of integrin α1 in mesangial cells and integrin α3 and vimentin in podocytes of Col4a3-null (Alport) mice.
Steenhard BM; Vanacore R; Friedman D; Zelenchuk A; Stroganova L; Isom K; St John PL; Hudson BG; Abrahamson DR
PLoS One; 2012; 7(12):e50745. PubMed ID: 23236390
[TBL] [Abstract][Full Text] [Related]
37. Genetic mutational testing of Chinese children with familial hematuria with biopsy‑proven FSGS.
Li Y; Wang Y; He Q; Dang X; Cao Y; Wu X; Mo S; He X; Yi Z
Mol Med Rep; 2018 Jan; 17(1):1513-1526. PubMed ID: 29138824
[TBL] [Abstract][Full Text] [Related]
38. A mouse Col4a4 mutation causing Alport glomerulosclerosis with abnormal collagen α3α4α5(IV) trimers.
Korstanje R; Caputo CR; Doty RA; Cook SA; Bronson RT; Davisson MT; Miner JH
Kidney Int; 2014 Jun; 85(6):1461-8. PubMed ID: 24522496
[TBL] [Abstract][Full Text] [Related]
39. Autosomal dominant Alport syndrome: molecular analysis of the COL4A4 gene and clinical outcome.
Marcocci E; Uliana V; Bruttini M; Artuso R; Silengo MC; Zerial M; Bergesio F; Amoroso A; Savoldi S; Pennesi M; Giachino D; Rombolà G; Fogazzi GB; Rosatelli C; Martinhago CD; Carmellini M; Mancini R; Di Costanzo G; Longo I; Renieri A; Mari F
Nephrol Dial Transplant; 2009 May; 24(5):1464-71. PubMed ID: 19129241
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome.
Prodromidi EI; Poulsom R; Jeffery R; Roufosse CA; Pollard PJ; Pusey CD; Cook HT
Stem Cells; 2006 Nov; 24(11):2448-55. PubMed ID: 16873763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
